Nordbeck, P., Goker-Alpan, O., Bernat, J. A., Germain, D. P., Giraldo, P., Jovanović, A., Kimonis, V., Nicholls, K., Rockman-Greenberg, C., Schiffmann, R., Thomas, M., Tylki-Szymanska, A., Wallace, E., Welford, R. W. D., West, M. L., Clozel, M., Frey, A., Trokan, L., Mueller, M. S., Vogler, M., Wanner, C., Hughes, D. (2026). Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension. Nature Communications. https://doi.org/10.1038/s41467-025-68256-5